← Back to Search

SUMMIT Tool for Chronic Pain

Phase 2 & 3
Waitlist Available
Led By William C Becker, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9-months
Awards & highlights

Study Summary

This trial is testing a mobile website to help veterans with chronic pain safely taper opioids while managing their pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
opioid dose

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SUMMITExperimental Treatment1 Intervention
Participants randomized to the experimental intervention will participate in a Motivational Interviewing (MI) session lasting between 30 and 60 minutes with study psychologist. All MI sessions will be audiotaped using a VA-approved digital recorder and transcribed verbatim. Participants will subsequently be shown how to access SUMMIT via a set of unique anonymized login credentials and to navigate the components of SUMMIT on one or more devices, depending on their preference. They will then be trained on how to complete the outcome surveys.
Group II: controlPlacebo Group1 Intervention
Participants randomized to the control intervention will use an eHealth comparator: My Pain Diary: Chronic Pain Management (iPhone, Android). This app includes a pain monitoring functioning only, and thus will only minimally overlap, if at all, with SUMMIT's components. Control participants will not participate in a MI session. Participants will download the app and be shown how to use the My Pain Diary app and trained how to complete the outcome surveys
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SUMMIT
2021
Completed Phase 3
~50

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,623 Previous Clinical Trials
3,324,733 Total Patients Enrolled
39 Trials studying Chronic Pain
4,713 Patients Enrolled for Chronic Pain
William C Becker, MDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT
2 Previous Clinical Trials
4,841 Total Patients Enrolled
1 Trials studying Chronic Pain
7 Patients Enrolled for Chronic Pain

Media Library

control Clinical Trial Eligibility Overview. Trial Name: NCT04746833 — Phase 2 & 3
Chronic Pain Research Study Groups: control, SUMMIT
Chronic Pain Clinical Trial 2023: control Highlights & Side Effects. Trial Name: NCT04746833 — Phase 2 & 3
control 2023 Treatment Timeline for Medical Study. Trial Name: NCT04746833 — Phase 2 & 3
~11 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top